title: Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?
authors.affiliation: Division of Hematology/Oncology, Beth Israel Deaconess Medical Center , Boston, MA , USA.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Brem
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Davids
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*